Arthur & Sonia Labatt Brain Tumour Research Centre
print        

Structure and organization

The BTRC is comprised of a research and training program under the directorship of Dr. James T. Rutka, MD, PhD and Dr. Ab Guha, MD, MSc (Associate Director, Research). One of the BTRC's strongest features is its networking with local, national and international experts engaged in all phases of cancer research.

The Director of the BTRC is accountable to the Advisory Board (listed below), and annually reports to the Board on: i) the ratio of grant capture funds to invested funds, ii) the number and quality of publications (including citation indices) that have resulted from funding for the BTRC, and iii) immediate and long-term recruitment plans. This process ensures that the benefactors, donors, hospitals and the University are apprised of the significant progress which will be made, and that appropriate international, University and Hospital codes of conduct are rigorously adhered to.

Advisory Board

Sonia and Arthur Labatt
Benefactors

Jim Wright
Surgeon-in-Chief, The Hospital for Sick Children

Janet Rossant
Chief, Research Institute, The Hospital for Sick Children

Ted Garrard
President, The Hospital for Sick Children Foundation

Mary-Jo Haddad
CEO, The Hospital for Sick Children

Robert S. Bell
CEO, University Health Network Foundation

Christopher Paige
Director Research, OCI/PMH

Catharine Whiteside
Dean, Faculty of Medicine, The University of Toronto

Helen Berman
Benefactor

David Berman
Scientific Advisor

Budget

The $15 million dollar endowment generously provided by Sonia and Arthur Labatt will be used to recruit scientists, post-doctoral fellows, graduate students and clinician-investigators to the BTRC. Funding will also be provided to support ongoing projects in experimental neuro-oncology and to initiate new projects, the data from which will serve as a platform from which new grants can be secured from internal and major external grants competitions.